These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6151903)

  • 1. Thyroid-stimulating immunoglobulins in insulin-dependent diabetes mellitus.
    Bliddal H; Bech K; Johansen K; Nerup J
    Eur J Clin Invest; 1984 Dec; 14(6):474-8. PubMed ID: 6151903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.
    Bech K; Nistrup Madsen S
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):47-58. PubMed ID: 583261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotrophin and thyroid-stimulating immunoglobulins have similar characteristics in activating human thyroid membrane adenylate cyclase.
    Ollis CA; MacNeil SM; Tomlinson S; Munro DS
    J Endocrinol; 1983 Apr; 97(1):137-43. PubMed ID: 6132954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P; Adler G; Roulier R; Lissitzky S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive method for assaying thyroid stimulating immunoglobulins of Graves' disease: use of the guanyl nucleotide-amplified thyroid adenylate cyclase assay.
    Macchia E; Carayon P; Fenzi GF; Lissitzky S; Pinchera A
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):345-51. PubMed ID: 6688318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies.
    Ilicki A; Gamstedt A; Karlsson FA
    J Clin Endocrinol Metab; 1992 May; 74(5):1090-4. PubMed ID: 1349025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of porcine and human thyroid tissue in the assay of thyroid stimulating immunoglobulins.
    de Rave S; Goldschmidt HM; Somers-Pijnenburg YT; Bravenboer B; Lockefeer JH
    Acta Endocrinol (Copenh); 1986 Nov; 113(3):335-9. PubMed ID: 2878548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FRTL-5 for the study of thyroid antibodies involved in goitrogenesis.
    Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Giachetti M; Pinchera A
    Thyroidology; 1992 Apr; 4(1):49-51. PubMed ID: 1284334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute changes in thyroid stimulating immunoglobulins, thyroglobulin and thyroglobulin antibodies following subtotal thyroidectomy.
    Bech K; Feldt-Rasmussen U; Bliddal H; Date J; Blichert-Toft M
    Clin Endocrinol (Oxf); 1982 Mar; 16(3):235-42. PubMed ID: 6122518
    [No Abstract]   [Full Text] [Related]  

  • 14. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.
    Macchia E; Concetti R; Carone G; Borgoni F; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases.
    Kasagi K; Hatabu H; Tokuda Y; Arai K; Iida Y; Konishi J
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):365-72. PubMed ID: 2898192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.
    Morita S; Izumi M; Nagataki S
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
    Smyth PP; McMullan NM; Grubeck-Loebenstein B; O'Donovan DK
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):321-30. PubMed ID: 2870597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
    Strakosch CR; Joyner D; Manley SW; Wall JR
    Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.